Market Share of Antibody Drug Conjugates Contract Manufacturing Industry
The antibody-drug conjugates contract manufacturing market is fragmented in nature, with several regional as well as international players. Some companies currently dominating the market are Lonza Group, Piramal Pharma Solutions, Abbvie Inc., Novasep, Merck KGaA, Cambrex Corporation, Recipharm, Thermo Fisher Scientific Inc., Cerbios-Pharma SA, and Sterling Pharma Solutions.
To gain a competitive edge, companies are putting in noteworthy efforts and capital investments toward expanding their capabilities, thereby enhancing their respective service portfolios. Some firms have also established new facilities dedicated to the manufacturing of highly potent compounds. The field has also observed the establishment of various partnerships between drug developers and ADC manufacturers.
Antibody Drug Conjugates Contract Manufacturing Market Leaders
Lonza Group
Abbvie, Inc.
Merck KGaA
Cambrex Corporation
Recipharm
*Disclaimer: Major Players sorted in no particular order
